Effect of proinflammatory cytokines on PIGA- hematopoiesis

Experimental Hematology

Volumn 31, Issue 9, 2003, Pages 770-778

  Kulkarni, Shashikant ^a   Bessler, Monica ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; FAS ANTIBODY; GAMMA INTERFERON; GLYCAN DERIVATIVE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHOSPHATIDYLINOSITOL GLYCAN CLASS A; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL POPULATION; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC ENGINEERING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STEM CELL; UPREGULATION;

EID: 0042235817     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00189-9     Document Type: Article

References (50)

1. Luzzatto L., Bessler M., Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 88:1997;1-4.
2. Takeda J., Miyata T., Kawagoe K., et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 73:1993;703-711.
3. Bessler M., Mason P.J., Hillmen P., et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 13:1994;110-117.
4. Armstrong C., Schubert J., Ueda E., et al. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1-murine lymphoma mutants. J Biol Chem. 267:1992;25347-25351.
5. Davitz M.A., Low M.G., Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med. 163:1986;1150-1161.
6. Rosse W.F. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood. 75:1990;1595-1601.
7. Dacie J.V., Lewis S.M. Paroxysmal nocturnal hemoglobinuria: variation in clinical severity and association with bone marrow hypoplasia. Br J Haematol. 7:1961;442-457.
8. Schrezenmeier H., Hertenstein B., Wagner B., Raghavachar A., Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol. 23:1995;81-87.
9. Maciejewski J.P., Rivera C., Kook H., Dunn D., Young N.S. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Br J Haematol. 115:2001;1015-1022.
10. Horikawa K., Nakakuma H., Kawaguchi T., et al. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood. 90:1997;2716-2722.
11. Kulkarni S., Bessler M. The effect of GPI-anchor deficiency on apoptosis in mice carrying a Piga gene mutation in hematopoietic cells. J Leukoc Biol. 72:2002;1228-1233.
12. Hinterberger W., Adolf G., Aichinger G., et al. Further evidence for lymphokine overproduction in severe aplastic anemia. Blood. 72:1988;266-272.
13. Schultz J.C., Shahidi N.T. Detection of tumor necrosis factor-α in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol. 45:1994;32-38.
14. Rosselli F., Sanceau J., Gluckman E., Wietzerbin J., Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood. 83:1994;1216-1225.
15. Hsu H.C., Tsai W.H., Chen L.Y., et al. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia. Exp Hematol. 24:1996;31-36.
16. Dufour C., Corcione A., Svahn J., et al. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol. 115:2001;1023-1031.
17. Rathbun R.K., Faulkner G.R., Ostroski M.H., et al. Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood. 90:1997;974-985.
18. Dror Y., Freedman M.H. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood. 97:2001;3011-3016.
19. Maciejewski J.P., Selleri C., Sato T., Anderson S., Young N.S. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol. 91:1995;245-252.
20. Chen R., Nagarajan S., Prince G.M., et al. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest. 106:2000;689-696.
21. Chen G., Kirby M., Zeng W., Young N.S., Maciejewski J.P. Superior growth of glycophosphatidyl inositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Exp Hematol. 30:2002;774-782.
22. Tremml G., Dominguez C., Rosti V., et al. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood. 94:1999;2945-2954.
23. Keller P., Payne J.L., Tremml G., et al. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med. 194:2001;581-589.
24. Lakso M., Pichel J.G., Gorman J.R., et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA. 93:1996;5860-5865.
25. Rosti V., Tremml G., Soares V., et al. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest. 100:1997;1028-1036.
26. Broxmeyer H.E., Williams D.E., Lu L., et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ J Immunol. 136:1986;4487-4495.
27. Wiesmann A., Kim M., Georgelas A., et al. Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta. Exp Hematol. 28:2000;128-139.
28. Selleri C., Maciejewski J.P., Sato T., Young N.S. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood. 87:1996;4149-4157.
29. Maciejewski J., Selleri C., Anderson S., Young N.S. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:1995;3183-3190.
30. Turner W., Chan S.P., Chirigos M.A. Stimulation of humoral and cellular antibody formation in mice by poly Ir:Cr. Proc Soc Exp Biol Med. 133:1970;334-338.
31. Pruett S.B., Fan R., Zheng Q. Acute ethanol administration profoundly alters poly I:C-induced cytokine expression in mice by a mechanism that is not dependent on corticosterone. Life Sci. 72:2003;1825-1839.
32. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
33. Murakami Y., Kinoshita T., Maeda Y., et al. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria. Blood. 94:1999;2963-2970.
34. Rotoli B., Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Baillieres Clin Haematol. 2:1989;113-138.
35. Broxmeyer H.E., Sherry B., Lu L., et al. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 76:1990;1110-1116.
36. Zoumbos N.C., Gascon P., Djeu J.Y., Young N.S. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA. 82:1985;188-192.
37. Whitney M.A., Royle G., Low M.J., et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 88:1996;49-58.
38. Nishimura J., Smith C.A., Phillips K.L., Ware R.E., Rosse W.F. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches. Hematopathol Mol Hematol. 11:1998;119-146.
39. Rizzo S., Killick S.B., Patel S., et al. Reduced TGF-β1 in patients with aplastic anaemia in vivo and in vitro. Br J Haematol. 107:1999;797-803.
40. Ridet A., Guillouf C., Duchaud E., et al. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1997;1722-1730.
41. Otsuki T., Nagakura S., Wang J., et al. Tumor necrosis factor-α and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice. J Cell Physiol. 179:1999;79-86.
42. Finkelman F.D., Svetic A., Gresser I., et al. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med. 174:1991;1179-1188.
43. Wathelet M.G., Berr P.M., Huez G.A. Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus. Eur J Biochem. 206:1992;901-910.
44. Nishimura Ji J., Hirota T., Kanakura Y., et al. Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria. Blood. 99:2002;2748-2751.
45. Araten D.J., Bessler M., McKenzie S., et al. Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia. 16:2002;2243-2248.
46. Paquette R.L., Yoshimura R., Veiseh C., et al. Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 96:1997;92-97.
47. Young N.S., Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 336:1997;1365-1372.
48. Cerwenka A., Bakker A.B., McClanahan T., et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
49. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol. 1:2000;119-126.
50. Nagakura S., Ishihara S., Dunn D.E., et al. Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. Blood. 100:2002;1031-1037.